Please type a search term (at least two characters)
Improvements in the life expectancy and health of individuals has been driven by constant innovation in the diagnosis and treatment of diseases and medical conditions. High quality healthcare is underpinned by the accurate physical, chemical and biological measurements used to diagnose health conditions and ensure therapies are delivered safely and effectively.
The rise in chronic diseases, such as cancer, neurodegenerative disorders and cardiovascular conditions, has resulted in an increase in technologically advanced screening, and diagnostics. Reliable and robust measurements are essential for implementing key healthcare regulations such as the Medical Device Directive, the In-vitro Diagnostic Directive and the legal framework which governs the safety, quality and performance of medicines and therapies. Metrology has had a critical role to play in ensuring that accurate measurements are available to assess the performance of new diagnostic methods and therapies, and ensure the effective treatment of patients.
The health projects funded under the EURAMET research programmes, EMRP and EMPIR, have brought together research groups from metrology institutes, academia, industry and clinicians to work collaboratively. These address the provision of accurate measurements to support healthcare in Europe. The EMRP health projects have been completed and highlights are available here. The EMPIR health projects are in progress and will be completed in 2019.
This report outlines the key technical achievements and early impacts of the group of projects completed under the EMRP Health theme. The report details the new measurement capabilities developed as a result of the collaborations within the Health projects.
Download the report